Quest Diagnostics

Quest Diagnostics Competitive Intelligence & Landscape

questdiagnostics.com ·

Overview

Quest Diagnostics Overview

Quest Diagnostics (questdiagnostics.com) is a leading provider of diagnostic information services, committed to creating a healthier world by delivering actionable insights from laboratory testing. The company's core services revolve around offering a wide array of lab tests, making appointments, managing billing and insurance, and providing easy access to test results for patients. They also cater to healthcare professionals with a comprehensive test directory, billing and coding support, and IT systems. Their value proposition centers on empowering individuals, physicians, and organizations to make informed decisions for improved health outcomes [https://ir.questdiagnostics.com/overview/default.aspx].

Quest Diagnostics serves a vast target market, including individual patients who can schedule appointments or purchase lab tests online, healthcare professionals like physicians and hospitals, health insurers, and businesses. Annually, Quest Diagnostics serves one in three adult Americans and half of the physicians and hospitals in the United States [https://www.questdiagnostics.com/our-company/about-us]. The company employs nearly 50,000 individuals who contribute to their purpose of transforming lives through diagnostic insights [https://newsroom.questdiagnostics.com/company-information].

While the exact founding year is not explicitly stated on the provided homepage content or the "About Us" page, the company has established a significant presence in the healthcare ecosystem.

Quest Diagnostics maintains its headquarters in the US and also operates internationally in India, Ireland, and Mexico, with its products and services reaching customers across six continents [https://www.questdiagnostics.com/our-company/international-locations]. The company emphasizes its commitment to quality, with all testing locations licensed/certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA 88) and accredited by the College of American Pathologists (CAP) [https://www.questdiagnostics.com/our-company/about-us/licenses-accreditations].

Quest Diagnostics

Quest Diagnostics Weekly Intel Updates

Receive weekly intel updates about Quest Diagnostics straight to your inbox.

Competitors

Quest Diagnostics Competitors

Laboratory Corporation of America Holdings (also known as Labcorp) is a primary competitor to Quest Diagnostics, offering a wide array of clinical testing services, including general health assessments, blood work, and genetic testing [https://mynucleus.com/blog/quest-diagnostics-vs-labcorp]. Both companies are among the largest and most trusted names in the market, providing services to millions of Americans. Their offerings are often compared across various factors such as billing practices, customer service quality, and the accuracy of their test results [https://mynucleus.com/blog/quest-diagnostics-vs-labcorp].

Thermo Fisher Scientific is another significant competitor, ranking highly in areas like diversity score compared to Quest Diagnostics [https://www.comparably.com/companies/quest-diagnostics/competitors]. While Quest Diagnostics focuses heavily on diagnostic information solutions, Thermo Fisher Scientific likely competes in broader areas of scientific research services and products, which can overlap with the diagnostic market.

Sonic Healthcare is a global healthcare provider and a direct competitor to Quest Diagnostics [https://craft.co/quest-diagnostics/competitors]. They provide similar diagnostic services and operate in the same market space, with both companies focusing on delivering comprehensive healthcare solutions to patients and providers.

Invitae specializes in medical genetic testing and stands as a competitor to Quest Diagnostics [https://craft.co/quest-diagnostics/competitors]. While Quest Diagnostics offers a broad range of tests, Invitae's focused expertise in genetic testing positions it as a strong contender for patients and healthcare professionals seeking specialized genomic insights. This niche focus differentiates Invitae from the more generalized diagnostic offerings of Quest Diagnostics.

Product & Pricing

Quest Diagnostics Product and Pricing Intelligence

Quest Diagnostics offers various products and services centered around lab testing and diagnostics for both patients and healthcare professionals. For individual patients, Quest Diagnostics provides the convenience of shopping for over 150 lab tests online at questhealth.com, which can be done without a doctor's visit. While specific pricing for these individual tests isn't directly available on questdiagnostics.com, patients can request a self-pay price estimate via email by providing the correct service code from their test order [patient.questdiagnostics.com/LP=163].

For healthcare professionals, Quest Diagnostics offers the Quanum® Lab Services Manager, a comprehensive portal designed to streamline lab-related tasks and provide insights [questdiagnostics.com/content/dam/corporate/unrestricted/documents/other/quanumforhcp/quanum_for_hcp_portal_brochure/quanum_for_hcp_portal_brochure.pdf]. This platform allows users to look up ICD codes, review specimen collection, track orders, schedule specimen pickups, and identify historical trends [provider.questdiagnostics.com/efficiency?elq=00000000000000000000000000000000&elqTrackId=b148d02df0bc46ffbcfb9a2ee932ffe1&elqaid=208&elqat=2]. The company also maintains a Quest Test Directory, a vast portfolio of over 3500 tests, accessible online to healthcare professionals [questdiagnostics.com/healthcare-professionals/test-directory].

Regarding pricing, Quest Diagnostics emphasizes transparency for health plan members through its Real-Time Estimation tool, which helps individuals understand the cost of their lab tests upfront [questdiagnostics.com/business-solutions/health-plans/promote-member-engagement]. For clients, pricing information can be looked up through the Order Code Price Inquiry page within their systems, requiring a client name or number and bill type to display [cas2.questdiagnostics.com/help/psc/content/topics/task/pricing_lookup_task.htm]. Furthermore, Quest Diagnostics offers an insurance lookup tool for patients to determine if their health plan is in-network, which can significantly impact out-of-pocket costs [insurance.questdiagnostics.com/].

Ad Campaigns

Quest Diagnostics Ad Campaigns

See the live ads Quest Diagnostics is running across Google, Meta, and LinkedIn — the creative, messaging, and platforms behind every campaign, updated automatically by ForesightIQ.

See of Quest Diagnostics's ads

View ads

Hiring & Layoffs

Quest Diagnostics Hiring and Layoffs

Currently, Quest Diagnostics (questdiagnostics.com) actively advertises over 2,000 job openings, signaling a robust and ongoing hiring strategy. The company is seeking to fill a diverse range of positions, including key roles such as Phlebotomist II Site Lead, Rep, Mobile Examiner, Billing Representative II, and Sr. Talent Acquisition Partner [careers.questdiagnostics.com/search-jobs]. These openings span critical areas including Phlebotomy, Laboratory Specimen processing, Drivers, Transportation and logistics, and Customer Service [careers.questdiagnostics.com/].

A notable aspect of Quest Diagnostics' hiring pattern is its emphasis on professional and technical roles. For instance, the company is recruiting a Senior Talent Acquisition Partner for Commercial Recruiting, indicating a strategic focus on expanding its commercial team and attracting top talent in this area [careers.questdiagnostics.com/job/tampa/senior-talent-acquisition-partner-commercial-recruiting/38852/96845925456]. Furthermore, there's a demand for specialized technical expertise, as seen in openings for a Bioinformatics Engineer – Software Development - PHP (Remote) within its Research and Development function [careers.questdiagnostics.com/job/seattle/bioinformatics-engineer-full-stack-software-development-hybrid/38852/84051759376] and a Medical Laboratory Scientist I [careers.questdiagnostics.com/job/indianapolis/medical-laboratory-scientist-i/38852/76091545664].

The company's hiring strategy also extends to critical operational and growth-oriented departments.

Quest Diagnostics is actively looking for various Account Executive roles in sales and marketing, including Precision Pathology Account Executive and Physician Account Executive positions, with 48 such jobs currently listed [careers.questdiagnostics.com/sales-marketing]. Additionally, a Digital Marketing Specialist role is open, focusing on planning, execution, and optimization of digital marketing efforts, highlighting a commitment to enhancing its online presence and customer engagement [careers.questdiagnostics.com/job/cincinnati/digital-marketing-specialist/38852/95323911808]. This broad recruitment across clinical, technical, sales, and marketing functions underscores a comprehensive strategy aimed at sustaining growth, improving customer service, and advancing its diagnostic capabilities.

Leadership

Quest Diagnostics Management and Leadership Team

Quest Diagnostics leadership is helmed by James E. Davis, who serves as Chairman, CEO, and President. He took on the role of CEO and President on November 1, 2022, and was subsequently elected Chairman of the Board on March 3, 2023 [https://newsroom.questdiagnostics.com/2023-03-03-Quest-Diagnostics-Board-of-Directors-Elects-James-E-Davis-Chairman-of-the-Board].

The executive team includes several key leaders. Richard Adams holds the position of Senior Vice President and General Manager, Consumer, while Murali Balakumar is a Senior Vice President [https://ir.questdiagnostics.com/financial-info/financial-tearsheet/default.aspx]. The company has also seen recent significant additions to its C-suite. In December 2023, Quest Diagnostics named Yuri A. Fesko, M.D., as Senior Vice President and Chief Medical Officer [https://newsroom.questdiagnostics.com/2023-12-20-Quest-Diagnostics-Names-Yuri-A-Fesko,-M-D-,-Senior-Vice-President-and-Chief-Medical-Officer], bringing his extensive experience as a medical oncologist and physician executive to the role [https://www.questdiagnostics.com/business-solutions/life-sciences/meet-the-experts/dr-yuri-fesko].

Further strengthening its leadership, Adrienne Brott joined Quest Diagnostics in January 2025 as Senior Vice President and Chief Quality and Regulatory Affairs Officer, bringing her expertise from companies like Getinge, BD, and J&J [https://newsroom.questdiagnostics.com/2025-01-08-Quest-Diagnostics-Names-Adrienne-Brott-Senior-Vice-President-and-Chief-Quality-and-Regulatory-Affairs-Officer]. More recently, in February 2026, Benjamin Beauvalot was appointed Senior Vice President, Chief Strategy and M&A Officer, having previously led M&A and transformation initiatives at Danaher and Patheon [https://newsroom.questdiagnostics.com/2026-02-26-Quest-Diagnostics-Names-Benjamin-Beauvalot-Senior-Vice-President,-Chief-Strategy-and-M-A-Officer].

The Board of Directors includes members such as Robert B. Carter and Luis A. Diaz, Jr., M.D., who also contribute to various committees, with James E. Davis serving on the Executive Committee [https://ir.questdiagnostics.com/governance/committee-composition/default.aspx]. Dan Haemmerle serves as Interim Vice President, Investor Relations, and VP Finance [https://ir.questdiagnostics.com/governance/board-of-directors/default.aspx].

Financials

Quest Diagnostics Financial Performance, Fundraising, M&A

Quest Diagnostics (questdiagnostics.com) has demonstrated robust financial performance, reporting substantial revenue growth and increasing its quarterly dividends. For the first quarter of 2026, the company posted revenues of $2.90 billion, marking a 9.2% increase from 2025, with organic revenue growth at 9.0%. Reported diluted earnings per share (EPS) for the same quarter were $2.24, up 15.5% from 2025, and adjusted diluted EPS reached $2.50, an increase of 13.1% from 2025. This strong start led Quest Diagnostics to raise its revenue and EPS guidance for the full year 2026, expecting reported diluted EPS to be between $9.58 and $9.78 [https://ir.questdiagnostics.com/financial-info/quarterly-results/default.aspx][https://newsroom.questdiagnostics.com/2026-04-21-Quest-Diagnostics-Reports-First-Quarter-2026-Financial-Results-Raises-Revenue-and-EPS-Guidance-for-Full-Year-2026].

Looking back at 2025, Quest Diagnostics also showcased significant financial health. In the fourth quarter of 2025, revenues were $2.81 billion, a 7.1% increase from 2024, with reported diluted EPS at $2.18, up 11% [https://ir.questdiagnostics.com/press-releases/press-release-details/2026/Quest-Diagnostics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results--Provides-Guidance-for-Full-Year-2026-Increases-Quarterly-Dividend-7-5-to-0-86-Per-Share/default.aspx][https://newsroom.questdiagnostics.com/2026-02-10-Quest-Diagnostics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-Provides-Guidance-for-Full-Year-2026-Increases-Quarterly-Dividend-7-5-to-0-86-Per-Share]. The company's third-quarter 2025 revenues were $2.82 billion, up 13.1% from 2024, with reported diluted EPS of $2.16, an 8.5% rise from 2024. Cash provided by operations year-to-date in 2025 was a notable $1.4 billion, up 63.1% from 2024 [https://ir.questdiagnostics.com/press-releases/press-release-details/2025/Quest-Diagnostics-Reports-Third-Quarter-2025-Financial-Results-Raises-Guidance-for-Full-Year-2025/default.aspx].

For the full year 2024, Quest Diagnostics reported total revenues of $9.87 billion, marking a 6.7% increase from 2023. The full year's reported diluted EPS stood at $7.69, reflecting a 2.7% increase from 2023. In recognition of its solid financial standing, the company increased its quarterly dividend by 7.5% to $0.86 per share in 2026, following a 6.7% increase to $0.80 per share in 2025 [https://ir.questdiagnostics.com/press-releases/press-release-details/2026/Quest-Diagnostics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results--Provides-Guidance-for-Full-Year-2026-Increases-Quarterly-Dividend-7-5-to-0-86-Per-Share/default.aspx][https://ir.questdiagnostics.com/press-releases/press-release-details/2025/Quest-Diagnostics-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-Provides-Guidance-for-Full-Year-2025-Increases-Quarterly-Dividend-6.7-to-0.80-Per-Share/default.aspx].

Partnerships

Quest Diagnostics Partnerships, Clients and Vendors

Quest Diagnostics (questdiagnostics.com) actively engages in strategic collaborations and technology integrations to enhance its diagnostic services and expand its market reach. A significant partnership includes a joint venture with Corewell Health to establish Diagnostic Lab of Michigan, LLC, aimed at improving laboratory services in Michigan ["https://ir.questdiagnostics.com/press-releases/press-release-details/2025/Corewell-Health-and-Quest-Diagnostics-to-Enter-into-Joint-Venture-Providing-Enhanced-Laboratory-Services-in-Michigan/default.aspx", "https://www.questdiagnostics.com/business-solutions/hospitals-health-systems/thoughtlab/corewell-health-and-quest-diagnostics-to-enter-into-joint-venture"].

The company also has key relationships within the healthcare ecosystem, such as being a preferred participating laboratory in the Optum Health Network's Preferred Lab Network ["https://www.questdiagnostics.com/healthcare-professionals/campaigns/optum"]. Furthermore, Quest Diagnostics serves as the exclusive independent lab provider for all Sentara Health Plans in Virginia and Florida, a collaboration designed to extend lab access in parts of the Southeast ["https://newsroom.questdiagnostics.com/2024-09-18-Sentara-Health-Plans-and-Quest-Diagnostics-Form-Strategic-Collaboration-to-Extend-Lab-Access-in-Parts-of-the-Southeast"].

Quest Diagnostics is committed to digital integration with healthcare systems. This includes a comprehensive collaboration with Epic, aiming to streamline and strengthen the customer experience through advanced integration ["https://newsroom.questdiagnostics.com/2025-09-23-Quest-Diagnostics-to-Improve-Laboratory-Testing-Experience-with-Industry-First-Epic-Collaboration"]. The company also integrates its Quanum® Enterprise Content Management with EMR and ERP systems to refine processes and improve collaboration ["https://www.questdiagnostics.com/business-solutions/hospitals-health-systems/enterprise-content-management/features-capabilities/systems-integrations"]. Additionally, Quest Diagnostics has partnered with Google Cloud to streamline its data operations ["https://newsroom.questdiagnostics.com/press-releases?item=137499"].

Notable clients benefiting from these partnerships include Northwestern Medicine, which enhanced efficiency and reduced costs through a strategic collaboration with Quest Diagnostics ["https://health.questdiagnostics.com/Collaboration"]. The company’s solutions are also designed to integrate easily into employer ecosystems, providing insights to help employers navigate employee health needs ["https://www.questdiagnostics.com/business-solutions/employers/improved-partnerships"].

Quest Diagnostics continues to expand its lab outreach programs by working with new and existing clients ["https://www.questdiagnostics.com/business-solutions/hospitals-health-systems/outreach-partnerships"].

Events

Quest Diagnostics Event Participations

Quest Diagnostics actively participates in various events, including conferences, webinars, and investor presentations. The company frequently engages with the financial community, for instance, by speaking at the Leerink 2026 Global Healthcare Conference [https://ir.questdiagnostics.com/events-and-presentations/default.aspx] and the Jefferies Healthcare Services Conference [https://ir.questdiagnostics.com/events-and-presentations/event-details/2025/Jefferies-Healthcare-Services-Conference-2025-bXTVRDH4qu/default.aspx]. Additionally, Quest Diagnostics hosts its own Investor Day, with a recent event held in March 2025 [https://ir.questdiagnostics.com/events-and-presentations/event-details/2025/Quest-Diagnostics-to-Host-Investor-Day-on-March-19-2025-2025-AwMzpojweF/default.aspx], and regularly holds earnings conference calls [https://ir.questdiagnostics.com/events-and-presentations/default.aspx].

For healthcare professionals, Quest Diagnostics provides extensive educational opportunities through its Clinical Education Center [https://www.questdiagnostics.com/healthcare-professionals/clinical-education-center]. This hub offers access to a variety of resources including educational webinars, podcasts, scientific publications, and conference presentations [https://www.questdiagnostics.com/healthcare-professionals/clinical-experts-education].

The company's educational content covers a broad range of topics, such as "Practical Applications of Pharmacogenomics To Improve Patient Outcomes" presented as an on-demand webinar [https://www.questdiagnostics.com/healthcare-professionals/clinical-education-center/webinars/2026/practical-applications-of-pharmacogenomics-to-improve-patient-outcomes].

Quest Diagnostics also hosts webinars on evolving diagnostics, including sessions like "Advancing Alzheimer's Diagnostics with the Power of Combined Plasma Biomarkers" and "The Evolving Role of Biomarkers in Alzheimer's Evaluation" [https://www.questdiagnostics.com/healthcare-professionals/clinical-education-center/webinars/2025/the-evolving-role-of-biomarkers-in-alzheimer-s-evaluation]. Furthermore, Quest Diagnostics exhibits at major events like the Alzheimer's Association International Conference (AAIC), which is a significant international gathering on the topic [https://www.questdiagnostics.com/healthcare-professionals/clinical-education-center/webinars/2025/advancing-alzheimer-s-diagnostics-with-the-power-of-combined-plasma-biomarkers].

Frequently Asked Questions

What is Quest Diagnostics' strategy for engaging with the financial community and investors?

Quest Diagnostics maintains an active engagement strategy with the financial community through frequent participation in investor presentations and conferences, such as the Leerink 2026 Global Healthcare Conference and the Jefferies Healthcare Services Conference. The company also hosts its own Investor Day, with a recent event in March 2025, and regularly conducts earnings conference calls to update stakeholders on financial performance and strategic direction.

How is Quest Diagnostics addressing the growing demand for specialized diagnostic knowledge in the healthcare industry?

Quest Diagnostics addresses the demand for specialized diagnostic knowledge through its Clinical Education Center, which offers extensive educational resources for healthcare professionals. This includes webinars, podcasts, and scientific publications on topics such as pharmacogenomics and advancing Alzheimer's diagnostics, demonstrating a commitment to supporting continuous learning and expertise in evolving diagnostic fields.

What does Quest Diagnostics' current hiring activity reveal about its strategic priorities?

Quest Diagnostics' current hiring of over 2,000 positions, including roles in Phlebotomy, Laboratory Specimen processing, and specialized technical fields like Bioinformatics Engineering, indicates a strategy focused on sustaining operational growth and enhancing diagnostic capabilities. The emphasis on Senior Talent Acquisition Partners and Account Executive roles also highlights a strategic push to expand commercial teams and market presence, especially in areas like Precision Pathology.

What recent executive appointments suggest a strategic focus on expanding Quest Diagnostics' market share and improving quality?

Recent executive appointments at Quest Diagnostics suggest a strategic focus on enhancing quality, regulatory affairs, and M&A for market expansion. Adrienne Brott joined in January 2025 as SVP and Chief Quality and Regulatory Affairs Officer, while Benjamin Beauvalot was appointed SVP, Chief Strategy and M&A Officer in February 2026. These additions, alongside the appointment of Yuri A. Fesko, M.D., as Chief Medical Officer in December 2023, indicate a concerted effort to strengthen operational excellence, strategic growth, and clinical leadership.

What signals from Quest Diagnostics' financials suggest confidence in future growth and shareholder returns?

Quest Diagnostics' financial performance signals confidence in future growth and shareholder returns through consistent revenue increases and raised guidance. For Q1 2026, revenues were $2.90 billion, up 9.2% from 2025, with an adjusted diluted EPS increase of 13.1%. The company raised its full-year 2026 EPS guidance and increased its quarterly dividend by 7.5% to $0.86 per share, following a 6.7% increase in 2025, reflecting a strong financial outlook.

How does Quest Diagnostics differentiate itself through partnerships and digital integration in the healthcare ecosystem?

Quest Diagnostics differentiates itself through strategic partnerships and extensive digital integration within the healthcare ecosystem. Collaborations like the joint venture with Corewell Health for Diagnostic Lab of Michigan, LLC, and its role as the exclusive independent lab provider for Sentara Health Plans, expand its market reach. Simultaneously, integrations with Epic, Quanum® Enterprise Content Management, and Google Cloud streamline data operations and enhance customer experience, illustrating a commitment to modernizing diagnostic service delivery.

What is Quest Diagnostics' approach to providing transparent pricing and access to lab tests for individual patients?

Quest Diagnostics offers individual patients online access to over 150 lab tests at questhealth.com, often without requiring a doctor's visit. While specific pricing isn't displayed publicly, patients can request self-pay price estimates via email using their test order service code. Additionally, the company provides a Real-Time Estimation tool for health plan members to understand upfront costs and an insurance lookup tool to check in-network status, promoting pricing transparency.

What specific tools does Quest Diagnostics provide healthcare professionals to enhance efficiency and access to diagnostic information?

Quest Diagnostics provides healthcare professionals with the Quanum® Lab Services Manager, a comprehensive portal that streamlines lab-related tasks. This platform allows users to look up ICD codes, review specimen collection guidelines, track orders, schedule specimen pickups, and identify historical trends. Additionally, the Quest Test Directory offers online access to a portfolio of over 3500 tests, enhancing efficiency and access to diagnostic information.

How does Quest Diagnostics position itself against specialized genetic testing companies like Invitae?

Quest Diagnostics, while offering a broad range of diagnostic services, competes against specialized genetic testing companies like Invitae by providing a comprehensive test directory that likely includes genetic tests. However, Invitae's focused expertise in medical genetic testing positions it as a strong competitor for healthcare professionals and patients seeking specialized genomic insights, suggesting Quest Diagnostics maintains a broader, more generalized diagnostic offering.

What is Quest Diagnostics' global operational footprint and how does it ensure quality across its international operations?

Quest Diagnostics maintains its headquarters in the US and operates internationally in India, Ireland, and Mexico, with products and services reaching customers across six continents. To ensure quality, all its testing locations are licensed and certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA 88) and accredited by the College of American Pathologists (CAP), establishing consistent quality standards globally.

How does Quest Diagnostics' relationship with Optum Health Network and Sentara Health Plans impact its market reach?

Quest Diagnostics' relationship as a preferred participating laboratory in the Optum Health Network's Preferred Lab Network, coupled with being the exclusive independent lab provider for all Sentara Health Plans in Virginia and Florida, significantly enhances its market reach. These collaborations extend lab access and service availability to a broader patient base, particularly in the Southeast United States, by integrating Quest Diagnostics into major health plan networks.

Powered by ForesightIQ · Competitive intelligence from digital exhaust